Ocular lichen planus treated with lifitegrast.

Int J Dermatol

Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA, USA.

Published: June 2021

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.15230DOI Listing

Publication Analysis

Top Keywords

ocular lichen
4
lichen planus
4
planus treated
4
treated lifitegrast
4
ocular
1
planus
1
treated
1
lifitegrast
1

Similar Publications

Introduction And Importance: Ocular involvement in lichen planus is highly uncommon, primarily affecting the eyelids, conjunctiva, and less frequently, the cornea. Peripheral ulcerative keratitis (PUK), a rare subtype form of corneal lichen planus, has been reported only once in the literature.

Case Presentation: The authors report details of a 34-year-old man with confirmed cutaneous lichen planus who developed severe PUK, a rare ocular manifestation of lichen planus.

View Article and Find Full Text PDF

Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) are mainly drug-induced severe cutaneous adverse reactions with increased mortality. It also involves the eyes causing ocular surface disease leading to visual impairment and blindness. The role of NLRP3 Inflammasome in causing ocular surface disease and keratinocyte apoptosis is not fully explored.

View Article and Find Full Text PDF

Key Clinical Message: The co-occurrence of myasthenia gravis (MG) and lichen planus (LP) is a rare phenomenon, with only 13 cases reported in the English literature between 1971 and 2024. Patients with MG or LP, regardless of the thymoma status, require close monitoring for other autoimmune diseases.

Abstract: Myasthenia gravis (MG) is an uncommon autoimmune disease, resulting in fatigable muscle weakness in the ocular, bulbar, and respiratory muscles, as well as muscles of the extremities.

View Article and Find Full Text PDF

Background: Lichen planus (LP) is a common inflammatory condition of unknown etiology that commonly affects the skin and mucous membranes. Optical coherence tomography angiography (OCTA) is a noninvasive technique for identifying early retinal vascular impairment in systemic disease without clinical damage by imaging deep and superficial capillary networks.

Aims: To assess the impacts of LP on the choroid and assess vascular changes in retinal capillary density using OCTA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!